Improving the secondary prevention of ST-elevation myocardial infarction

Secondary prevention medications following ST-elevation myocardial infarction (STEMI) have been established with NICE and European Society of Cardiology guidelines.[1,2][1] In practice, while most patients with STEMI are discharged with the correct secondary prevention medications,[3][2] titration